Rapid absorption selective 5-HT agonist formulations

Details for Australian Patent Application No. 2004212976 (hide)

Owner Biovail Laboratories Inc.

Inventors Mezaache, Djelila; Frisbee, Steve; Maes, Paul; Mezaache, Naima

Agent Shelston IP

Pub. Number AU-A-2004212976

PCT Pub. Number WO2004/073632

Priority 60/447,741 19.02.03 US

Filing date 18 February 2004

Wipo publication date 2 September 2004

International Classifications

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/073632 Priority application(s): WO2004/073632

10 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212978-Fire-retardant mattress

2004212970-Cigarette having porous heat transfer tube